Trained as a medicinal biochemist, Mr. Brown has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic and 6 vaccine products. Collectively, these products save the lives of over 5.6 million people annually and generated over $35B of revenue in 2020.
Fred Brown comes to the fight against the COVID-19 virus from a forty year career developing pharmaceutical solutions to fight infectious diseases and solving the myriad challenges involved in suppressing epidemics including HIV, H5N1, Ebola, Zika, measles and malaria. His extensive experience managing past pandemics are accelerating and supporting personal, business and government responses to COVID-19 around the world.
Fred has an unmatched ability to integrate his experience and education with analyses of data from medical, scientific, and economic sources, and help leaders interpret the data to develop effective action plans.
Fred has been assisting 17 U.S. state governments, 5 national governments, several agencies, 2 NGO’s and selected mayors with their COVID response at no charge during this outbreak.
Unlike many people with academic, medical and pharmaceutical credentials, Fred is fortunate to be self-employed, and can speak his mind without regard to constraints imposed by an employer or affiliated institution. His motivation in engaging full-time with this pandemic crisis is a deep understanding, experience set and personal desire to help solve it; he has no commercial interests to advance.
I see myself as a truth-telling antigen, trying to stimulate the world’s immune system to respond more robustly to the threat. My goal is to help people think clearly about the huge issues raised by the COVID-19 pandemic. – Fred Brown
EXPERIENCE
- Epidemic Intervention
- Developing and commercializing first test for HIV (Centocor/
DuPont)
- Developing and commercializing polyvalent vaccines (GSK,
Novartis, others)
- Managing Roche Diagnostics and Tamiflu suppression of
H5N1 Influenza
- Developing and commercializing first test for HIV (Centocor/
- Pharmaceutical Development
- Led or supported the discovery, development and/or launch
of 27 pharmaceutical, 13 diagnostic and 6 vaccine products
saving 5.6M lives per year and achieving combined peak sales
of over $35B
- Global Head, Hoffmann LaRoche Product Lifecycle,
Partnerships and Informatics
- Co-founder of Alkermes (NASDAQ: ALKS). Member, Boards of
Directors of several venture-backed device, diagnostic,
healthcare and therapeutic companies.
- Led or supported the discovery, development and/or launch
- Health Policy and Technology Management
- Founded and led the Healthcare and Life Sciences Divisions
of Andersen Consulting (Accenture) and IBM in the US, and in
EU, Middle East and Africa (EMEA). Under Mr. Brown’s
leadership, first Andersen and then IBM became the largest healthcare consulting services companies in the world.
- Developed and built the R&D applications and technical
backbone supporting clinical trials and product
commercialization of pharmaceutical companies, regulators
and contract research organizations worldwide
- President of the largest independent specialty pharmacy and
Head of Innovation and Growth at the largest not-for-profit
hospital system
- Founded and led the Healthcare and Life Sciences Divisions
EDUCATION
- Tufts University, B.S. 1981, Magna Cum Laude, Biology and Geology
- Harvard University, MBA, 1985
CURRENT COMMITMENTS
- Johns Hopkins Medical School/ES4P, Board Member of Continuing Medical Education
- University of Michigan, Adjunct Faculty and Social Venture Fund, Health Sector Lead
- Board Member, PreDxion Biosciences and Warmilu, Inc.
FIND FRED ON SOCIAL
- Twitter: @fredbro04649138
- LinkedIn: @frederickwkbrown
- Website: www.fredbrown.com